BICALUTAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bicalutamide, and what generic alternatives are available?
Bicalutamide is a drug marketed by Accord Hlthcare, Adaptis, Apotex, Chartwell Rx, Fresenius Kabi Usa, Kudco Ireland, Rising, Roxane, Sandoz, Sun Pharm, Synthon Pharms, Teva, and Watson Labs Teva. and is included in thirteen NDAs.
The generic ingredient in BICALUTAMIDE is bicalutamide. There are twenty-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bicalutamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bicalutamide
A generic version of BICALUTAMIDE was approved as bicalutamide by ACCORD HLTHCARE on July 6th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BICALUTAMIDE?
- What are the global sales for BICALUTAMIDE?
- What is Average Wholesale Price for BICALUTAMIDE?
Summary for BICALUTAMIDE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 144 |
| Clinical Trials: | 184 |
| Patent Applications: | 5,998 |
| Drug Prices: | Drug price information for BICALUTAMIDE |
| What excipients (inactive ingredients) are in BICALUTAMIDE? | BICALUTAMIDE excipients list |
| DailyMed Link: | BICALUTAMIDE at DailyMed |
Recent Clinical Trials for BICALUTAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1 |
| University of California, San Francisco | Phase 1 |
| Changhai Hospital | N/A |
Pharmacology for BICALUTAMIDE
| Drug Class | Androgen Receptor Inhibitor |
| Mechanism of Action | Androgen Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for BICALUTAMIDE
US Patents and Regulatory Information for BICALUTAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | BICALUTAMIDE | bicalutamide | TABLET;ORAL | 078917-001 | Jul 6, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | BICALUTAMIDE | bicalutamide | TABLET;ORAL | 079185-001 | Jul 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | BICALUTAMIDE | bicalutamide | TABLET;ORAL | 091011-001 | Jun 10, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | BICALUTAMIDE | bicalutamide | TABLET;ORAL | 076932-001 | Jul 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roxane | BICALUTAMIDE | bicalutamide | TABLET;ORAL | 078285-001 | Mar 24, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Adaptis | BICALUTAMIDE | bicalutamide | TABLET;ORAL | 079089-001 | Jul 6, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apotex | BICALUTAMIDE | bicalutamide | TABLET;ORAL | 200274-001 | May 21, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
